The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Katunina E.A.

Pirogov Russian National Research Medical University;
Federal Center for Brain and Neurotechnologies

Shipilova N.N.

Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Titova N.V.

Pirogov Russian National Research Medical University;
Federal Center for Brain and Neurotechnologies

Malykhina E.A.

Pirogov Russian National Research Medical University;
Federal Center for Brain and Neurotechnologies

Zhuk V.A.

Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Ivanova M.Z.

Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Creativity in patients with Parkinson’s disease

Authors:

Katunina E.A., Shipilova N.N., Titova N.V., Malykhina E.A., Zhuk V.A., Ivanova M.Z.

More about the authors

Read: 1410 times


To cite this article:

Katunina EA, Shipilova NN, Titova NV, Malykhina EA, Zhuk VA, Ivanova MZ. Creativity in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(11):128‑132. (In Russ.)
https://doi.org/10.17116/jnevro2019119111128

Recommended articles:
Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138
Musculoskeletal diso­rders in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11-2):6-10
«Brain—gut—microbiome» axis in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11-2):18-23
Higher-level ambu­lation diso­rders in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11-2):32-38
Epidemiology of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11-2):39-54

References:

  1. Miller BL, Ponton M, Benson DF, Cummings JL, Mena I. Enhanced artistic creativity with temporal lobe degeneration. Uncet. 1996;348:1744-1745. https://doi.org/10.1016/s0140-6736(05)65881-3
  2. Miller BL, Cummings J, Mishkin F, Boone K, Prince F, Ponton M, Cotman C. Emergence of artistic talent in frontotemporal dementia. Neurology. 1998;51:978-982.  https://doi.org/10.1212/wnl.51.4.978
  3. Bogousslavsky J. Artistic creativity, style and brain disorders. European Neurology. 2005;54:103-111.  https://doi.org/10.1159/000088645
  4. Mell JC, Howard SM, Miller BL. Art and the brain: The influence of frontotemporal dementia on an accomplished artist. Archives of Neurology. 2003;60:1707-1712. https://doi.org/10.1212/01.wnl.0000064164.02891.12
  5. Zanaboni DC, Porta M, Saleh C, Servello D. Creativity assessment in subjects with tourette syndrome vs. patients with Parkinson’s disease: A Preliminary Study. Brain Sci. 2017;7(7):80.  https://doi.org/10.3390/brainsci7070080
  6. Gilford Dzh. Tri storony intellekta. Sb.: Psikhologiya myshleniya. M.: Progress; 2005. (In Russ.).
  7. Golubeva EA, Izyumova SA, Kabardov MK, Kadirov BR, Matova MA, Pechenkov VV, Suvorova VV, Tichomirova IV, Turovskya ZG, Usim ED. Experience in a comprehensive study of students in connection with some problems of differentiation of education. Voprosy Psikhologii. 2010;2. (In Russ.).
  8. Chakravarty A. The creative brain-revisiting concepts. Medical Hypotheses. 2010;74:606-612.  https://doi.org/10.1016/j.mehy.2009.10.014
  9. Flaherty AW. Brain illness and creativity: Mechanisms and treatment risks. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 2011;56:132-143.  https://doi.org/10.1177/070674371105600303
  10. Faust-Socher A, Kenett YN, Cohen OS, Hassin-Baer S, Inzelberg R. Enhanced creative thinking under dopaminergic therapy in Parkinson disease. Ann Neurol. 2014;75(6):935-942.  https://doi.org/10.1002/ana.24181
  11. Bindler L, Anheim M, Tranchant C, Vidailhet P. La créativité du patient parkinsonien. Annales Médico-Psychologiques. 2011;169:104-107.  https://doi.org/10.1016/j.amp.2010.10.001
  12. Schräg A, Trimble M. Poetic talent unmasked by treatment of Parkinson’s disease. Movement Disorders. 2011;16:1175-1176. https://doi.org/10.1002/mds.1239
  13. Walker RH, Warwick R, Cercy SP. Augmentation of artistic productivity in Parkinson’s disease. Movement Disorders. 2006;21:285-286.  https://doi.org/10.1002/mds.20758
  14. Chatterjee A, Hamilton RH, Amorapanth PX. Art produced by a patient with Parkinson’s disease. Behavioural Neurology. 2006;17:105-108.  https://doi.org/10.1155/2006/901832
  15. Inzelberg R, Schechtman E, Hocherman S. Visuo-motor coordination deficits and motor impairments in Parkinson’s disease. PLoS One. 2008;3:3663. https://doi.org/10.1371/journal.pone.0003663
  16. Witt K, Krack P, Deuschl G. Change in artistic expression related to subthalamic stimulation. Joumal of Neurotogy. 2006;253:955-956.  https://doi.org/10.1007/s00415-006-0127-x
  17. Bodis-Wollner I. Retinopathy in Parkinson Disease. Journal of Neural Transmission. 2009;116:1493-1501. https://doi.org/10.1007/s00702-009-0292-z
  18. Joutsa J, Martikainen K, Kaasinen V. Parallel appearance of compulsive behaviors and artistic creativity in Parkinson’s disease. Neurol. 2012;4(1):77-83.  https://doi.org/10.1159/000338759
  19. Kulisevsky J, Pagonabarraga J, Martinez-Corral M. Changes in artistic style and behaviour in Parkinson’s disease: Dopamine and creativity. Journal of Neurology. 2009;256:816-819.  https://doi.org/10.1007/s00415-009-5001-1
  20. Joutsa J, Martikainen K, Niemelä S, Forsback S, Rinne J, Kaasinen V. Increased medial orbitofrontal [18F] fluorodopa uptake in Parkinsonian impulse control disorders. Movement Disorders. 2012;27(6):778-782.  https://doi.org/10.1002/mds.24941
  21. Carlsson I, Wendt PE, Risberg J. On the neurobiology of creativity. Differences in frontal activity between high and low creative subjects. Neuropsychologia. 2000;6:873-885.  https://doi.org/10.1016/s0028-3932(99)00128-1
  22. Fink A, Grabner RH, Benedek M, Neubauer AC. Divergent thinking training is related to frontal electroencephalogram alpha synchronization. Eur J Neurosci. 2006;8:2241-2246. https://doi.org/10.1111/j.1460-9568.2006.04751.x
  23. Snyder A, Mitchell J, Bossomaier T, Pallier G. The creativity quotient: an objective scoring of ideational fluency. Creat Res J. 2004;4:415-419.  https://doi.org/10.1080/10400410409534552
  24. Canesi M, Rusconi ML, Cereda E, Ranghetti A, Cereda V, Moroni F, Pezzoli G. Divergent Thinking in Parkinsonism: A Case-Control Study. Front Neurol. 2017;8:534.  https://doi.org/10.3389/fneur.2017.00534
  25. Lim SY, Evans AH, Miyasaki JM. Impulse control and related disorders in Parkinson’s disease: review. Ann NY Acad Sci. 2008;1142:85-107.  https://doi.org/10.1196/annals.1444.006
  26. Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P. ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2017;88(4):317-324.  https://doi.org/10.1136/jnnp-2016-315277
  27. Sarathchandran P, Soman S, Sarma G, Krishnan S, Kishore A. Impulse control disorders and related behaviors in Indian patients with Parkinson’s disease. Mov Disord. 2013;28(13):1901-1902. https://doi.org/10.1002/mds.25557
  28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV-TR). American Psychiatric Publishing. Washington, DC. 2000.
  29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed). Arlington V.A.: American Psychiatric Publishing; 2013.
  30. Pontone G, Williams JR, Bassett SS, Marsh L. Clinical features associated with impulse control disorders in Parkinson’s disease. Neurology. 2006;67(7):1258-1261. https://doi.org/10.1212/01.wnl.0000238401.76928.45
  31. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KN, Duda JE, Moberg PJ, Stern MB. Association of dopamine agonist use with impulse control disorders in Parkinson’s disease. Arch Neurol. 2006;63(7):969-973.  https://doi.org/10.1001/archneur.63.7.969
  32. Shipilova NN, Titova NV, Kokaeva ZG, Fedosova AS, Klimov EA, Katunina EA. A clinical and genetic study of impulsive-compulsive disorders in patients with Parkinson`s disease. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(10):4-9. (In Russ.). https://doi.org/10.17116/jnevro20181181014
  33. Schwingenschuh P, Katschnig P, Saurugg R, Ott E, Bhatia KP. Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson’s disease. Movement Disorders. 2010;25:493-496.  https://doi.org/10.1002/mds.22936
  34. Canesi M, Rusconi ML, Isaias IU, Pezzo HG. Artistic productivity and creative thinking in Parkinson’s disease. European Journal of Neurology. 2012;19:468-472.  https://doi.org/10.1111/j.1468-1331.2011.03546.x
  35. Evans AH, Stegeman JR. Punding in patients on dopamine agonists for restless leg syndrome. Movement Disorders. 2009;24:140-141.  https://doi.org/10.1002/mds.22309
  36. Flaherty AW. Frontotemporal and dopaminergic control of idea generation and creative drive. J Comp Neurol. 2005;1:147-153.  https://doi.org/10.1002/cne.20768
  37. Canesi M, Rusconi ML, Moroni F, Ranghetti A, Cereda E, Pezzoli G. Creative thinking, professional artists, and Parkinson’s disease. J Parkinsons Dis. 2015;1:239-246.  https://doi.org/10.3233/jpd-150681
  38. Klimov EA. Psikhologiya professional’nogo samoopredeleniya. Ucheb. posobie dlya stud. vyssh. ped. ucheb. zavedenii. M.: Akademiya; 2004. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.